Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience

Craig R. Nichols, Scott Saxman, Stephen D. Williams, Patrick J. Loehrer, Michael E. Miller, Cameron Wright, Lawrence H. Einhorn

Research output: Contribution to journalArticle

96 Scopus citations


Between 1976 and 1988, 31 patients with mediastinal nonseminomatous germ cell tumors (MNGCT) received initial cisplatin-based chemotherapy of uniform intensity. Eighteen of these patients (58%) obtained disease-free status; 11 with chemotherapy alone and seven with adjunctive surgery. Eleven have remained continuously free of disease. Two have had recurrence of teratoma and are disease-free after resection of teratoma at 12+ and 68+ months. Three patients developed recurrence of germ cell tumor. Three patients developed a hematologic malignancy. Of the 18 patients who obtained disease-free status, 15 remain alive and disease-free. Overall, 13 of the 31 patients and 24 other patients received salvage chemotherapy at Indiana University, Indianapolis, Indiana. Of these 37 patients, six obtained a disease-free status and four (11%) remain alive at 13+, 56+, 78+, and 122+ months, respectively. This series represents the largest series of patients with MNGCT ever reported. Analysis of these data and results from other recent series suggest that approximately 50% of patients with MNGCT will be cured with modern, intense cisplatin-based chemotherapy coupled with adjunctive surgery if needed.

Original languageEnglish (US)
Pages (from-to)1641-1646
Number of pages6
Issue number7
StatePublished - Apr 1 1990

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience'. Together they form a unique fingerprint.

  • Cite this